Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial is evaluating the efficacy and safety of Cannabidiol Oral Solution for focal seizures and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Seizures

Drugs mentioned

• Cannabidiol Oral Solution (CBD-OS) (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Focal Seizures | Phase 1 | Status: RECRUITING